Lifecore Biomedical

Quarterly Financials

Values in thousands 2024-08-31 2024-05-31 2024-02-29 2023-11-30
Revenue
$24,705
$37,886
$31,546
$30,150
Gross Profit
5,387
17,272
8,391
9,957
EBITDA
-8,894
4,639
-2,598
EBIT
-10,887
3,246
-5,714
Net Income
-16,230
-7,083
-36,130
14,218
Net Change In Cash
24,705
37,886
31,546
30,150
Free Cash Flow
-4,035
6,127
-25,733
-2,973
Cash
5,520
8,462
19,091
3,221
Basic Shares
30,855
30,563
30,322
30,459

Annual Financials

Values in thousands 2024-05-31 2023-05-31 2022-05-31 2021-05-31
Revenue
$128,261
$185,786
$185,786
$544,161
Gross Profit
41,850
50,553
50,370
81,474
EBITDA
812
1,963
-68,029
13,004
EBIT
-7,188
-5,136
-85,913
4,396
Net Income
12,013
-46,084
-97,431
-32,665
Net Change In Cash
128,261
185,786
185,786
544,161
Free Cash Flow
-18,138
-52,533
-52,533
-8,752
Cash
8,462
1,643
1,643
1,295
Basic Shares
36,658
29,466
29,513
29,294

Earnings Calls

Quarter EPS
2024-08-31
-$0.49
2024-05-31
-$0.17
2024-02-29
$0.42
2023-11-30
-$0.13